Fundamentals for Faron Pharmaceuticals Oy (DI) ( farn )
Current Price: 0.96
Market Cap: 68.77m
Price / Net Assets: -5.99
Internal Rate of Return: -100%
PE10 Ratio: -4.16
Dividend Yield: 0%
Currency: £ GBP
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | Average |
|---|---|---|---|---|---|---|---|---|---|
| Revenue (m) | £0m | £0m | £0m | £0m | £0.02m | £1.15m | £0.52m | £0.91m | £0m |
| Revenue Growth | - | - | - | -100.00% | -98.26% | 121.15% | -42.86% | - | -17% |
| Profit / Loss | £-28.73m | £-21.19m | £-16.94m | £-13.26m | £-20.09m | £-9.29m | £-6.19m | £-1.36m | £-15m |
| Profit Increase/Decrease | 35.58% | 25.09% | 27.75% | -34.00% | 116.25% | 50.08% | 355.15% | - | 82% |
| Profit / Sales Ratio | - | - | - | - | - | - | - | - | 0% |
| Earnings per Share | £-0.52 | £-0.42 | £-0.37 | £-0.36 | £-0.65 | £-0.39 | £-0.30 | £-0.09 | £-0.39 |
| Total Debt | £22.75m | £10.26m | £10.22m | £8.60m | £7.63m | £6.41m | £3.64m | £3.35m | £9.11m |
| Net Assets | £-11.48m | £2.92m | £-1.85m | £1.61m | £0.37m | £10.88m | £11.18m | £-1.19m | £1.56m |
| Debt / Asset Ratio | 201.86% | 77.85% | 122.10% | 84.23% | 95.38% | 37.07% | 24.56% | 155.09% | 155.09% |
| Dividend per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0.00% |
| Dividend Cover | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0x | 0.00x |